Filing metadata

Accession number
0001209191-22-005930
Form type
Form 3
Filer
Aclaris Therapeutics, Inc.
CIK
CIK 1557746
Filed
Feb 01, 2022
Reporting period
Jan 31, 2022
Description
Initial ownership

Explore SEC Filings Hub